Scientists
Cyclin-Dependent Kinase 1 Inhibitor RO-3306 Enhances P53-Mediated Apoptosis in Acute Myeloid Leukemia
Researchers from Wakayama, Japan have investigated the effect of cyclin-dependent kinase 1 (CDK1) inhibition on p53 signaling in acute myeloid leukemia (AML) cells. The study, published in Cancer Science, found that treatment with the CDK1 inhibitor RO-3306 induces G2/M-phase cell cycle arrest and apoptosis in AML cells in a